A significant increase in Treg frequency expressed as FoxP3 + Tcells as a proportion of CD4 + CD25 + cells was recorded in women with cervical cancer (11.00 ± 19.79%) compared to the controls (1.71 ± 8.91%), (p < 0.0001) (Table 1). This evidence concerns the gene CD4 and cervical carcinoma.